![Glenn L. Stoller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Glenn L. Stoller
Corporate Officer/Principal bei The Retina Society
Profil
Glenn L.
Stoller is the founder of SKS Ocular LLC.
He is currently a member of The Retina Society and the American Society of Retinal Specialists.
Previously, he was a director at the American Academy of Ophthalmology, Inc. and the chief scientific officer at Ohr Pharmaceutical, Inc. He holds a doctorate degree from New York University.
Aktive Positionen von Glenn L. Stoller
Unternehmen | Position | Beginn |
---|---|---|
The Retina Society | Corporate Officer/Principal | - |
American Society of Retinal Specialists | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Glenn L. Stoller
Unternehmen | Position | Ende |
---|---|---|
Ohr Pharmaceutical, Inc.
![]() Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | - |
SKS Ocular LLC
![]() SKS Ocular LLC BiotechnologyHealth Technology SKS Ocular, LLC is a private ophthalmology company incubator that uses state-of-the-art research and development technologies to discover and advance novel therapeutics through preclinical or clinical proof of concept. | Gründer | - |
American Academy of Ophthalmology, Inc.
![]() American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Direktor/Vorstandsmitglied | - |
Ausbildung von Glenn L. Stoller
New York University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
American Academy of Ophthalmology, Inc.
![]() American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Commercial Services |
The Retina Society | |
Ohr Pharmaceutical, Inc.
![]() Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Health Technology |
American Society of Retinal Specialists | |
SKS Ocular LLC
![]() SKS Ocular LLC BiotechnologyHealth Technology SKS Ocular, LLC is a private ophthalmology company incubator that uses state-of-the-art research and development technologies to discover and advance novel therapeutics through preclinical or clinical proof of concept. | Health Technology |